RxDoctor Payments Data

Bradley Clark, DO

Clinical Cardiac Electrophysiology · Indianapolis, INNPI 1447510722

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (30.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 72.0% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $19,910 and has fallen 87.5% since, to $2,494 in 2025.

$44,658in general payments, 2019–2025

Across 204 payments — averaging $218.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$32K
  • Abbott$6K
  • Boston Scientific$5K
  • Biosense Webster, Inc.$405
  • Atricure, Inc.$207
  • Impulse Dynamics (USA) Inc.$183
  • plus $476 from 6 others
$13,950in research payments, 2019–2025

Across 1 payment — averaging $13,950 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Atricure, Inc.$14K

What the payments were for

  • Consulting fees$1,4003%
  • Speaking & faculty fees$6,45014%
  • Grants$13,40130%
  • Travel & lodging$11,51826%
  • Food & beverage$11,88827%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$44,658 in reported general payments places this provider in the 75th percentile of 72 clinical cardiac electrophysiology providers in Indiana.

See all clinical cardiac electrophysiology providers in Indiana

Medicare billing

Part B allowed, 2024
$281,667
Medicare patients
683
Services billed
4,180

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban414$501,102
XareltoRivaroxaban99$124,728
EntrestoSacubitril/Valsartan35$45,961
MultaqDronedarone Hcl24$36,973
Metoprolol Succinate503$8,161
Dofetilide59$7,955
Dabigatran EtexilateDabigatran Etexilate Mesylate14$4,920
SotalolSotalol Hcl208$4,667
Flecainide Acetate98$4,539
Amiodarone Hcl156$3,746
Mexiletine Hcl26$3,022
Diltiazem 24hr Er (Cd)Diltiazem Hcl75$2,952
Propafenone Hcl14$1,849
Nebivolol Hcl12$1,698
Digoxin54$1,216

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →